Treatment of Juvenile Myoclonic Epilepsy with Myoclonic Seizures in Adults (16 Years and Older)
This protocol covers the initial management of juvenile myoclonic epilepsy (JME) in patients 16 years of age and older who present with myoclonic seizures.
Clinical Scenario
Adults aged 16 and older presenting with myoclonic seizures in the context of juvenile myoclonic epilepsy.
Treatment Approach
First-line management begins with monotherapy using an indicated antiepileptic drug, with agent selection guided by seizure type and individual patient factors.
The complete regimen — specific agent options, selection criteria, and clinical algorithm — is available in the full protocol.
References
- Adults
- Myoclonic
- Treatment should begin with monotherapy.
- The appropriate choice of medication varies depending on seizure type.
- Level C: carbamazepine, lamotrigine, oxcarbazepine, phenobarbital, phenytoin, topiramate, valproic acid
- Level D: gabapentin, levetiracetam, vigabatrin
View source ↗